Annual report 2023
A unique network with strong partners.
Key figures
Financial key figures
Net sales
in million CHF
EBIT adjusted
in million CHF
Dividend
in CHF per share
Key social figures
Number of employees as of 31.12.2023
Investment in employee development in million CHF
Availability of medicinal products on average 2023
Key environmental figures
Energy consumption from renewable sources
Energy intensity in MWh/FTE
Waste is recycled on average 2023
Management report
Galenica Group sales performed well in 2023, growing 4.4% to CHF 3,746.0 million. The adjusted EBIT increased slightly to CHF 191.3 million.
![Woman in the camp smiles into the camera](/galenica23Assets/img/publikationen/weblication/wThumbnails/90e1c06e-4ae1949f@1680w.png)
![Supplier and pharmacist smile at each other](/galenica23Assets/img/publikationen/weblication/wThumbnails/fbef9295-4ae1949f@811w.jpg)
Report on non-financial matters pursuant to Art. 964a of the Swiss Code of Obligations
In accordance with the provisions of the Swiss Code of Obligations (CO), we are hereby publishing a report on non-financial matters pursuant to Art. 964a et seq. for the first time for the 2023 financial year.
![iPad in the hand](/galenica23Assets/img/corporate-information/weblication/wThumbnails/2023_01_galenica_ct_office_m086_0258-05a6851b-4ae1949f@811w.jpg)
![Jürg Pauli, Portrait](/galenica23Assets/img/management/weblication/wThumbnails/6aa093b4-db5257eb@1440w.jpg)
«Today more than ever, sustainability has become a central pillar of business activity.»
Jürg Pauli, Chief Transformation Officer